Equity Overview
Price & Market Data
Price: $0.447
Daily Change: $0.00 / 0.00%
Daily Range: $0.38 - $0.463
Market Cap: $13,294,711
Daily Volume: 1,492,041
Performance Metrics
1 Week: -4.02%
1 Month: -67.61%
3 Months: -70.78%
6 Months: -80.04%
1 Year: -86.85%
YTD: -70.78%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: Canada
Details
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.